- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01857258
Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction
February 14, 2017 updated by: Richard Bruno, Ohio State University
The objective of this study is to formulate and validate a green tea confection (i.e.
"gummy" candy) as a strategy to attenuate postprandial hyperglycemia-induced impairments in vascular function.
The central hypothesis is that a green tea confection will protect against vascular endothelial dysfunction by suppressing postprandial hyperglycemia.
The central hypothesis of this application will be assessed by developing a green tea-containing confection, examining its physiochemical properties and its inhibition of starch digestion, and then validating its vasoprotective activities in healthy humans by assessing its blood glucose-regulating activities.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study involves validating a green tea confection (i.e.
"gummy" candy) as a dietary strategy to attenuate postprandial hyperglycemia-induced impairments in vascular function.
The central hypothesis is that a green tea confection will protect against vascular endothelial dysfunction by suppressing postprandial hyperglycemia.
The central hypothesis of this application will be assessed by providing research participants 75 grams of carbohydrate in the form of a confection that contains no green tea concentrate or green tea concentrate at a level equivalent to approximately 3 cups of freshly brewed tea.
Blood glucose and brachial artery flow-mediated dilation will be assessed at regular intervals during the 3 hour postprandial period to define the extent to which green tea attenuates postprandial increases in blood glucose and decreases in vascular function that otherwise occur in a hyperglycemia-dependent manner.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 28 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Plasma glucose <100 mg/dL
- Plasma total cholesterol <200 mg/dL
- Plasma triglycerides <140 mg/dL
- Blood pressure <140/90
- non-dietary supplement user for >2 months
- no use of medications known to affect carbohydrate metabolism,
- nonsmoker / never smoker
- no history of cardiovascular disease or gastrointestinal disorders
Exclusion Criteria:
- allergies or aversions to green tea and/or corn starch,
- excessive alcohol consumption (>3 drinks/d),
- >5 h/wk of aerobic activity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Green Tea
Participants will be provided a confection containing green tea concentrate
|
Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose
|
Active Comparator: Control
Participants will be provided a confection devoid of green tea concentrate
|
Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Area Under the Curve of Blood Glucose
Time Frame: Area under the Curve, 0, 30, 60, 90, 120, 150, 180 minutes post-dose
|
Blood glucose will be measured at 0, 30, 60, 90, 120, 150 and 180 minutes following the ingestion of a confection to calculate area under the concentration-time curve.
|
Area under the Curve, 0, 30, 60, 90, 120, 150, 180 minutes post-dose
|
Area Under the Curve of Brachial Artery Flow Mediated Dilatiion
Time Frame: Area under the Curve, 0, 30, 60, 90, 120, 150, 180 minutes post-dose
|
Brachial artery flow-mediated dilation will be measured at 0, 30, 60, 90, 120, 150, and 180 minutes following the ingestion of a confection.
|
Area under the Curve, 0, 30, 60, 90, 120, 150, 180 minutes post-dose
|
Brachial Artery Flow-mediated Dilation
Time Frame: 0 min (baseline)
|
0 min (baseline)
|
|
Brachial Artery Flow-mediated Dilation
Time Frame: 60 min
|
60 min
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Malondialdehyde (0 Min)
Time Frame: Baseline (0 min)
|
Baseline (0 min)
|
Malondialdehyde
Time Frame: 60 min postprandially
|
60 min postprandially
|
Ratio of Asymmetric Dimethylarginine Relative to Arginine
Time Frame: 0 min (baseline)
|
0 min (baseline)
|
Ratio of Asymmetric Dimethylarginine Relative to Arginine
Time Frame: 60 min (baseline)
|
60 min (baseline)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2013
Primary Completion (Actual)
February 1, 2015
Study Completion (Actual)
April 1, 2016
Study Registration Dates
First Submitted
May 16, 2013
First Submitted That Met QC Criteria
May 16, 2013
First Posted (Estimate)
May 20, 2013
Study Record Updates
Last Update Posted (Actual)
February 16, 2017
Last Update Submitted That Met QC Criteria
February 14, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013H0116
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperglycemia
-
Mayo ClinicCompletedHospital Hyperglycemia | Post-transplant HyperglycemiaUnited States
-
Zealand University HospitalNot yet recruitingStress Hyperglycemia | Postoperative Hyperglycemia
-
University of CopenhagenUnknownSurgery--Complications | Hyperglycemia Stress | Hyperglycemia Steroid-inducedDenmark
-
University of LeedsCompletedEffect of Food on Postprandial HyperglycemiaUnited Kingdom
-
Emory UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...RecruitingHyperglycemia StressUnited States
-
Loughborough UniversityUniversity of BedfordshireCompletedPostprandial HyperglycemiaUnited Kingdom
-
Centre Hospitalier Universitaire de BesanconEli Lilly and Company; AstraZenecaCompleted
-
Medical University of ViennaCompleted
-
Addis Ababa UniversityCompletedHyperglycemia, Postprandial
-
University of Eastern FinlandFinnsugar LtdCompletedHyperglycemia, PostprandialFinland
Clinical Trials on Green Tea Concentrate
-
The University of Hong KongCompleted
-
Taipei City HospitalNational Yang Ming UniversityCompletedType 2 Diabetes | HyperlipidemiaTaiwan
-
Chiang Mai UniversityCompletedHyperuricemia | GoutThailand
-
University of ArizonaUnited States Department of DefenseCompletedLung Cancer Prevention
-
University of MinnesotaNational Cancer Institute (NCI)Completed
-
Charite University, Berlin, GermanyCompleted
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Texas Tech University Health Sciences CenterNational Center for Complementary and Integrative Health (NCCIH)Completed
-
University of AberdeenLipton Teas and InfusionsRecruitingThe Focus of the Study is Healthy VolunteersUnited Kingdom
-
Hayder Raad AbdulbaqiActive, not recruiting